The International Institute of Molecular and Cell Biology in Warsaw (IIMCB) stands at the forefront of life sciences research, dedicated to uncovering the mechanisms that govern organisms at the cellular and molecular levels. With a commitment to both basic and applied research, the IIMCB seeks to deepen our understanding of the biological foundations of life.
Research areas
Focusing primarily on RNA and cell biology, the Institute aims to understand the fundamentals of human disease, which is the basis for the development of innovative therapeutic and diagnostic methods. IIMCB’s research focuses on infectious, neurological, oncological, and rare diseases.
Poland’s top research institute
The Institute has consistently received the highest scientific category (A+) in evaluations conducted by the Ministry of Science and Higher Education of Poland.
Unique legal status
IIMCB was established in 1995 by an international agreement between the Government of the Republic of Poland and UNESCO, and further confirmed by the Act of the Polish Parliament of June 26, 1997, the Institute was granted special status. This recognition ensures the Institute’s independence and international character and brings it into line with the standards of the world’s leading research institutions.
Dynamic growth
The IIMCB is in a phase of dynamic scientific and institutional growth. The Institute continues to expand its research capacity and infrastructure while maintaining a strong focus on RNA and cell biology. Research groups operate within and across these two areas, reflecting both disciplinary depth and scientific collaboration. The ongoing development of core facilities ensures that researchers have access to the tools and technologies needed to address increasingly complex biological questions. A dedicated Technology Transfer Office supports efforts to connect research with practical applications. This integrated approach positions IIMCB as a centre where high-quality science is supported by a forward-looking research environment.
Strategic Projects Driving IIMCB’s Growth
Since 2023, the Institute has been leading the EU-funded RACE project (RNA and Cell Biology – from Fundamental Research to Therapies), aimed at transforming the IIMCB into a world-class center of excellence in RNA and cell biology. Another initiative, RACE-PRIME, focuses on developing new approaches to treat diseases currently lacking effective therapies. Additionally, funding from the National Recovery Plan supports the purchase of cutting-edge research infrastructure. These three strategic grants, fueled by both national and international funding, are the pillars of the Institute’s growth.
Strategic Projects Driving IIMCB’s Growth
